{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:50:25Z","timestamp":1791651025878,"version":"4.3.4"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.arr.2026.103331","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:03:41Z","timestamp":1787673821000},"page":"103331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Anti-amyloid drugs: Integrated clinical pathways for treating older patients with frailty and dementia"],"prefix":"10.1016","volume":"122","author":[{"given":"Vincenzo","family":"Solfrizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madia","family":"Lozupone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7220-0656","authenticated-orcid":false,"given":"Francesco","family":"Panza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2026.103331_bib1","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1016\/S2666-7568(20)30059-3","article-title":"Changes in the severity and lethality of age-related health deficit accumulation in the USA between 1999 and 2018: a population-based cohort study","volume":"2","author":"Blodgett","year":"2021","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.arr.2026.103331_bib2","volume":"6","author":"Borda","year":"2015","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.arr.2026.103331_bib3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/01.wnl.0000324864.81179.6a","article-title":"Physical frailty in older persons is associated with Alzheimer disease pathology","volume":"72","author":"Buchman","year":"2008","journal-title":"Neurology"},{"issue":"2025","key":"10.1016\/j.arr.2026.103331_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10654-025-01220-1","article-title":"Generalizability of trial criteria on amyloid-lowering therapy against Alzheimer's disease to individuals with mild cognitive impairment or early Alzheimer's disease in the general population","volume":"40","author":"Claus","year":"2025","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.arr.2026.103331_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13024-024-00719-7","article-title":"The concept of resilience to Alzheimer's Disease: current definitions and cellular and molecular mechanisms","volume":"19","author":"de Vries","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2026.103331_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijcard.2017.01.153","article-title":"The prevalence of frailty in heart failure: a systematic review and meta-analysis","volume":"236","author":"Denfeld","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.arr.2026.103331_bib7","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(19)31785-4","article-title":"Management of frailty: opportunities, challenges, and future directions","volume":"394","author":"Dent","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2026.103331_bib8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S1474-4422(23)00447-7","article-title":"European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders","volume":"23","author":"Frisoni","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2026.103331_bib9","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s43587-021-00099-3","article-title":"The degree of frailty as a translational measure of health in aging","volume":"1","author":"Howlett","year":"2021","journal-title":"Nat. Aging"},{"key":"10.1016\/j.arr.2026.103331_bib10","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1186\/s12889-023-16097-6","article-title":"Social vulnerability indices: a scoping review","volume":"23","author":"Mah","year":"2023","journal-title":"BMC Public. Health"},{"key":"10.1016\/j.arr.2026.103331_bib11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13195-023-01272-z","article-title":"Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis","volume":"15","author":"Mattke","year":"2023","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2026.103331_bib12","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1002\/alz.13161","article-title":"Predicting amyloid-beta pathology in the general population","volume":"19","author":"Nguyen Ho","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103331_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1474-4422(18)30446-0","article-title":"Understanding frailty to predict and prevent dementia","volume":"18","author":"Panza","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2026.103331_bib14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jamaneurol.2025.1734","article-title":"Amyloid-beta pathology and cognitive performance in centenarians","volume":"82","author":"Rohde","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103331_bib15","article-title":"Why frailty must be central in anti-amyloid therapies for Alzheimer's disease.J.","volume":"29","author":"Ruiz","year":"2025","journal-title":"Nutr. Health Aging"},{"key":"10.1016\/j.arr.2026.103331_bib16","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jalz.2019.04.013","article-title":"Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging","volume":"15","author":"Solfrizzi","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103331_bib17","first-page":"394","article-title":"Relationship between frailty and Alzheimer's disease biomarkers: a scoping review","volume":"10","author":"Wallace","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103331_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70312","article-title":"The first 25 years of the Northwestern University SuperAging Program","volume":"21","author":"Weintraub","year":"2025","journal-title":"Alzheimers Dement."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726003235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726003235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:07:14Z","timestamp":1791648434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163726003235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":18,"alternative-id":["S1568163726003235"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2026.103331","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-amyloid drugs: Integrated clinical pathways for treating older patients with frailty and dementia","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2026.103331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103331"}}